No Data
No Data
Express News | Linotebo: Net profit fell 43.5% year on year in 2023
Linuo Tebo (301188.SZ): The borosilicate medicinal glass tube project has been produced according to the design plan
Gelonghui, April 12 | Linuotebo (301188.SZ) said on the investor interactive platform that the borosilicate medicinal glass tube project has been produced according to the design plan. The pass rate meets the design requirements, and can produce about 5,000 tons of products per year, mainly for the company's own use in the production of borosilicate control bottles.
Linuo Tebo (301188.SZ): The controlling shareholder transferred a total of 700,000 “Linuo Convertible Bonds”
Glonghui on March 6 | Linuo Tebo (301188.SZ) announced that on March 6, 2024, the company received a notice from Linuo Investment, the controlling shareholder, and learned that between March 1, 2024 and March 5, 2024, it transferred a total of 700,000 “Linuo Convertible Bonds” in bulk transactions through the Shenzhen Stock Exchange System, accounting for 14.00% of the total amount issued. After this change, Linuo Investment, the controlling shareholder of the company, held 856,151 “Linuo Convertible Bonds”, accounting for 17.12% of the total issuance volume.
Linuo Tebo (301188.SZ): 1.40% of shares have been repurchased cumulatively
Glonghui, March 4 | Linuottebo (301188.SZ) announced that as of February 29, 2024, the company used its own funds to repurchase a total of 3,255,000 shares through a dedicated securities account, accounting for 1.40% of the company's current total share capital. The highest transaction price for the repurchased shares was 16.00 yuan/share, and the minimum transaction price was 12.339 yuan/share. The total transaction amount was 45,642,890.54 yuan (excluding transaction fees).
Linuo Tebo (301188.SZ): Currently, the company's borosilicate molded bottles are in the normal related approval stage
Gelonghui, Feb. 19: An investor asked Linuotebo (301188.SZ) on the investor interactive platform, “Shandong Dingxin Pharmaceutical Packaging Group applied for transfer to A, and the company hasn't transferred A yet, is the company's product not working?” The company replied that currently the company's borosilicate molded bottle is in the normal related approval stage and is progressing in an orderly manner according to the plan. Follow-up progress The company will promptly fulfill its disclosure obligations in accordance with relevant laws and regulations. Please stay tuned for the company's subsequent relevant announcements.
Linuo Tebo (301188): China borosilicate medicine glass faucet accelerates growth and a breakthrough in molded bottle expansion is imminent
Leading specialty glass enterprises, pharmaceutical glass upgrades and growth are accelerating. The company was founded in 2002 and began production of high borosilicate heat-resistant glass and low borosilicate pharmaceutical glass. In 2017-2022, the company's operating income and net profit to mother started at 5.0/
No Data